Konstantinos Xynos, Chief Medical Officer at Replimune Group, Inc. (REPL), sold 15,904 shares at $8.06 ($128K) on 2025-05-20, disclosed to the SEC on 2025-05-22.
Open-market sale of $128k REPL by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.06 | 7,952 | $64K | 50.0% |
| 2 | $8.06 | 7,952 | $64K | 50.0% |
| Total | $8.06 avg | 15,904 | $128K | 100% |
| Filing → |
| REPL | SELL | 2025-11-19 | $132K | — | Filing → |
| REPL | SELL | 2024-11-20 | $156K | — | Filing → |
| REPL | SELL | 2024-06-10 | $238K | — | Filing → |